Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:1546-1550

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGill, H. C.
Right arrow Articles by Strong, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGill, H. C., Jr
Right arrow Articles by Strong, J. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Diabetes Complications
*High Blood Pressure
*Nutrition
*Obesity
*Smoking
*Smoking and Youth
Related Collections
Right arrow Risk Factors

(Circulation. 2001;103:1546.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Effects of Nonlipid Risk Factors on Atherosclerosis in Youth With a Favorable Lipoprotein Profile

Henry C. McGill, Jr, MD; C. Alex McMahan, PhD; Arthur W. Zieske, MD; Gray T. Malcom, PhD; Richard E. Tracy, MD, PhD; Jack P. Strong, MD; for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group

From The University of Texas Health Science Center at San Antonio (H.C.M, C.A.M), San Antonio, Tex; Southwest Foundation for Biomedical Research (H.C.M.), San Antonio, Tex; and the Louisiana State University Medical Center (A.W.Z., G.T.M., R.E.T., J.P.S.), New Orleans, La.

Correspondence to Henry C. McGill, Jr, MD, Southwest Foundation for Biomedical Research, PO Box 760549, San Antonio, TX 78245-0549. E-mail jstron{at}lsumc.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—The strong association between coronary heart disease and dyslipoproteinemia has often overshadowed the effects of the nonlipid risk factors–smoking, hypertension, obesity, and diabetes and impaired glucose tolerance–and even led to questioning the importance of these risk factors in the presence of a favorable lipoprotein profile.

Methods and Results—A cooperative multicenter study, the Pathobiological Determinants of Atherosclerosis in Youth (PDAY), examined the relation of the nonlipid risk factors to atherosclerosis in 629 men and 227 women 15 to 34 years of age who died of external causes and who had a favorable lipoprotein profile (non-HDL cholesterol <4.14 mmol/L [<160 mg/dL] and HDL cholesterol >=0.91 mmol/L [>=35 mg/dL]). In the abdominal aorta, smokers had more extensive fatty streaks and raised lesions than nonsmokers, and hypertensive blacks had more raised lesions than normotensive blacks. In the right coronary artery, hypertensive blacks had more raised lesions than normotensive blacks, obese men (body mass index >=30 kg/m2) had more extensive fatty streaks and raised lesions than nonobese men, and individuals with impaired glucose intolerance had more extensive fatty streaks. Obese men had more severe lesions (American Heart Association grade 2 through 5) of the left anterior descending coronary artery.

Conclusions—These substantial effects of the nonlipid risk factors on the extent and severity of coronary and aortic atherosclerosis, even in the presence of a favorable lipoprotein profile, support the need to control all cardiovascular risk factors.


Key Words: coronary disease • risk factors • atherosclerosis


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
In 50 years of attempts to control the 20th century epidemic of coronary heart disease (CHD), attention was focused primarily on hypercholesterolemia1 because its association with CHD was strong and consistent, it was a plausible intervening variable, and lowering blood cholesterol decreased CHD risk.2 Although control of hypertension, smoking, diabetes, and obesity was recommended as part of most prevention regimens,3 their importance was often overshadowed by the strength of the cholesterol effect. Sometimes even the necessity of dealing with the other risk factors in the absence of hypercholesterolemia was questioned.

We investigated the effects of the nonlipid risk factors on atherosclerosis in young persons with a favorable lipoprotein profile using data from the multicenter cooperative project Pathobiological Determinants of Atherosclerosis in Youth (PDAY), which collected material from {approx}3000 15- to 34-year-old trauma victims autopsied in forensic laboratories. The results show that these nonlipid risk factors deserve attention even in the presence of a favorable lipoprotein profile.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Study Design
Fifteen cooperating centers adopted standardized methods to collect specimens and data and to analyze them in central laboratories.

Subjects
Study subjects were persons 15 through 34 years of age who died of external causes (accidents, homicides, or suicides) within 72 hours of injury and were autopsied within 48 hours of death in one of the cooperating forensic laboratories. Age and race were obtained from the death certificate. We collected 2876 acceptable cases from June 1, 1987, to August 31, 1994. Data on all risk factors were available for 1479 cases. The Institutional Review Board of each cooperating center approved this study.

Dissecting and Preserving Arteries
PDAY investigators bisected the aorta longitudinally and fixed the left half in 10% neutral buffered formalin. They opened the right coronary artery (RCA) longitudinally and fixed it in the same manner. They perfused the left main artery and left anterior descending coronary artery (LAD) with 10% buffered formalin at a pressure of {approx}100 mm Hg (130 cm H2O) and dissected them from the heart. A central laboratory stained the aortas and RCAs with Sudan IV and packaged them in plastic bags.

In another central laboratory, a technician cut a 5-mm transverse block from the fixed LAD distal to the flow divider of the left main and left circumflex arteries. Sections from the proximal half were stained with oil red O (ORO), and sections from the distal half were stained with Gomori-trichrome aldehyde fuchsin (GTAF). Of the cases having data on all risk factors, microscopic sections of the LAD were available for 760 cases.

Grading Atherosclerosis
Three pathologists independently estimated the extent of intimal surface area of the RCA and abdominal aorta involved with fatty streaks and raised lesions by procedures described in previous publications.4 The consensus grade was the average of the grades of the 3 pathologists. Of the cases having data on all risk factors, assessment of extent of gross lesions was available for 1458 abdominal aortas and 1427 RCAs.

Two pathologists graded GTAF- and ORO-stained sections using the American Heart Association (AHA) classification system5 6 as described in a previous publication.7 Differences were resolved by discussion, and a consensus grade was reached.

Risk Factor Assessment
Methods of measuring CHD risk factors were presented in previous publications4 8 9 and are summarized in Table 1Down. We based the criterion for a favorable lipoprotein profile on the recommendation of the National Cholesterol Education Program3 : LDL cholesterol <3.4 mmol/L (<130 mg/dL) and HDL cholesterol >=0.91 mmol/L (>=35 mg/dL). We assumed that an LDL cholesterol concentration of 130 mg/dL was approximately equal to a non-HDL cholesterol concentration of 4.14 mmol/L (160 mg/dL).10 Of the PDAY cases with data on all risk factors, 856 cases (629 men and 227 women) had a favorable lipoprotein profile.


View this table:
[in this window]
[in a new window]
 
Table 1. Nonlipid Risk Factors, Samples, Analyses, Risk Classification Criteria, Prevalence of Risk Factors in All PDAY Cases, and Prevalence in Cases With a Favorable Lipoprotein Profile

Statistical Procedures
Extent of intimal surface area involved with atherosclerotic lesions was analyzed by multiple regression analysis. We included all effects found to be important in previous analyses.4 8 9 These were the effects of sex, race, 5-year age group, smoking status, hypertension, obesity, and elevated glycohemoglobin, as well as the interactions between age and the risk factors, between race and hypertension, and between sex and obesity. Because of the limited number of cases, effects higher than second order were not included. A logit transformation, with a small constant added to avoid the logarithm of zero, was applied to the extent of surface area involved.

Because the number of cases for which we had microscopic grades was small, we combined AHA grades 0 or 1 and grades 2, 3, 4, or 5 for statistical analysis using logistic regression. We included the effects of sex, race, 5-year age group, smoking, hypertension, obesity, elevated glycohemoglobin, and the sex-by-obesity interaction.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Prevalence of Lipid and Nonlipid Risk Factors
Table 1Up gives the prevalence of nonlipid risk factors in all PDAY subjects and the prevalence of nonlipid risk factors among subjects with a favorable lipoprotein profile. Of the individuals with a favorable lipoprotein profile, 38.8% had no nonlipid risk factors; 47.3% had 1 nonlipid risk factor, of whom 68.6% were smokers; 13.1% had 2 nonlipid risk factors (smoking and hypertension were the most prevalent combination); 0.7% had 3 nonlipid risk factors; and 0.1% had all 4 nonlipid risk factors.

Effect of Nonlipid Risk Factors on Gross Lesions
Table 2Down gives the effects of nonlipid risk factors on fatty streaks and raised lesions in the presence of a favorable lipoprotein profile. The effects are presented as the ratio of extent involvement at the high level of a risk factor (as defined in Table 1Up) to the extent involvement at the desirable level of a risk factor. Men had less extensive fatty streaks than women (ratio <1.0) in the abdominal aorta, but men and women had about an equal extent of raised lesions. In contrast, although men had only slightly more extensive fatty streaks in the RCA than women (ratios slightly >1.0, P=NS), they developed considerably more extensive raised lesions in both the 15- to 24-year-old and 25- to 34-year-old age groups.


View this table:
[in this window]
[in a new window]
 
Table 2. Ratio of Percent Intimal Surface Area Involved for High Level of a Risk Factor to Involvement for Low Level of the Risk Factor by 10-Year Age Group, in Subjects With a Favorable Lipoprotein Profile

Smoking was associated with more extensive fatty streaks in the abdominal aorta in both the 15- to 24-year-old and 25- to 34-year-old age groups and with a much greater extent of raised lesions in the abdominal aorta of 25- to 34-year-old subjects. It had little effect on the extent of either type of lesion in the RCA.

Hypertension was associated with a greater extent of raised lesions in the abdominal aorta and RCA of blacks. Hypertension tended to be associated with more extensive raised lesions in whites, but the effect was smaller than in blacks of the same age. We believe that the ratio of 0.55 for raised lesions in the abdominal aorta of younger whites is due to the low prevalence of hypertension in the younger age group and does not represent a real effect of hypertension. Hypertension was not associated with fatty streaks in either whites or blacks.

Obesity was associated with more extensive fatty streaks in the RCAs of 15- to 24-year-old men and with more extensive raised lesions in both 15- to 24-year-old and 25- to 34-year-old men. Obesity was not associated with either fatty streaks or raised lesions in the RCAs or aortas of women.

Elevated glycohemoglobin was associated with more extensive fatty streaks in the RCAs of 15- to 24-year-old men and women, but the associations with raised lesions were not significant, probably because of the low prevalence of elevated glycohemoglobin.

Effects of Nonlipid Risk Factors on Microscopic Characteristics of Lesions
Eighteen (4.2%) of 430 cases had AHA grade 4 to 5 (advanced) lesions in the LAD. One of the women with a grade 4 to 5 lesion had no risk factors, and 3 had 1 risk factor. Three of the men with a grade 4 to 5 lesion had no risk factors, 5 had 1 risk factor, and 6 had 2 risk factors. Table 3Down shows the odds ratios for AHA grades 2 to 5 (fatty streaks and advanced lesions) versus AHA grades 0 to 1 (normal and isolated foam cells). All of the odds ratios (except that for smoking) were substantially >1.0, and the odds ratios for male sex and obesity in men were statistically significant. The lack of statistical significance is probably due to the limited number of cases.


View this table:
[in this window]
[in a new window]
 
Table 3. OR for Risk Factor Effects on Microscopic Characteristics of Lesions (AHA Grades 2–5 vs AHA Grades 0–1) in Subjects With a Favorable Lipoprotein Profile

Effect of Combined Risk Factors
The FigureDown compares the extent of raised lesions in the RCAs of persons who did not smoke, were normotensive, were not obese, and had normal glycohemoglobin with the extent of raised lesions in persons who smoked, were hypertensive, were obese, and had elevated glycohemoglobin. All had a favorable lipoprotein profile. The differences were substantial, even in the 15- to 19-year-old age group and in both men and women. Differences became greater in succeeding age groups and were 5-fold higher in men aged 30 to 34 years. These risk factor profiles illustrate the extreme profiles of no risk factors and all risk factors. The extent of raised lesions for other profiles will be intermediate.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Extent of intimal surface involved with raised lesions in RCA by nonlipid risk profile, sex, race, and age in subjects with favorable lipoprotein profile. Low-risk individuals are nonsmokers, are not hypertensive, have body mass index <30 kg/m2, and have glycohemoglobin <8%. High-risk individuals are smokers, are hypertensive, have BMI >=30 kg/m2, and have glycohemoglobin >=8%. T bar represents standard error.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Summary of Results
The nonlipid risk factors—smoking, hypertension, obesity, and impaired glucose tolerance—accelerate atherogenesis in the presence of a favorable lipoprotein profile in young people. Hence, an unfavorable lipoprotein profile is not a necessary condition for progression of atherosclerosis in young people. Control of dyslipidemia alone will undoubtedly retard the progression of atherosclerosis in young persons, but there will remain a substantial atherogenic stimulus from smoking, hypertension, obesity, and hyperglycemia.

Male Sex
Although male sex is not among the mutable risk factors, the results presented here emphasize the more rapid progression of coronary atherosclerosis in young men than in young women. This difference is not explained by established risk factors. The difference between young men and young women in atherosclerotic lesions precedes the difference between the sexes in clinical CHD at older ages. This observation is consistent with the concept that risk factor reduction in young people will prevent or delay the development of clinical CHD.

Smoking
The strongest effect of smoking is on a localized region of the dorsolateral aspect of the distal third of the abdominal aorta.11 The effect is evident in the late teenage years and becomes stronger in later decades. This finding is consistent with the well-established association of smoking with abdominal aortic aneurysm.12 Smoking is associated with a higher microscopic grade of coronary artery fatty streaks in young people,7 but a stronger effect on raised lesions becomes evident after age 35.13 Smoking is associated with increased risk of clinical CHD in the presence of low serum cholesterol levels,14 a finding consistent with the results reported here.

Hypertension
In the PDAY study, hypertension was the only risk factor that affected raised lesions but not fatty streaks.9 This effect remained strong in the presence of a favorable lipoprotein profile. As in previous analyses of these cases, the effect was stronger in blacks, probably due to the greater severity of hypertension in blacks.

Obesity
Obesity is the only risk factor in the PDAY study that affects atherosclerotic lesions in men but not in women.8 Its effect is not explained by other risk factors. The present results show that obesity does not depend on the presence of an unfavorable lipoprotein profile to accelerate atherogenesis.

Impaired Glucose Tolerance
In a previous analysis of PDAY cases,8 elevated glycohemoglobin was associated with a significant 3-fold excess of raised lesions in the RCAs of persons 15 to 24 years of age and a 5-fold excess in persons 25 to 34 years of age, even when adjusted for other risk factors. In this smaller number of cases with a favorable lipoprotein profile, the effect was significant only for RCA fatty streaks. The ratios (Table 2Up) for raised lesions were greater than 1.0 but not significantly greater, probably because the number of cases having elevated glycohemoglobin was too small.

Limitations of Study
Because emergency medical teams often administer large quantities of intravenous fluids to some individuals immediately before death from violent causes, we excluded serum values from cases having total cholesterol <2.59 mmol/L (100 mg/dL).4 The selection of desirable lipoprotein profiles having non-HDL cholesterol and HDL cholesterol concentrations at opposite ends of the distributions also minimizes the potential effects of hemodilution. Although agonal procedures may degrade associations, we do not believe that they are likely to produce spurious associations.

Comparison With Other Studies
The effects of the nonlipid risk factors reported here are consistent with the risk factor effects estimated from all PDAY cases.4 7 8 9 11 Those analyses did not indicate interactions between the lipid and nonlipid risk factors. Because those analyses used a larger number of cases, some risk factor effects were statistically significant, whereas effects of similar magnitude were not statistically significant in the smaller number of cases analyzed for the present report.

The Bogalusa Heart Study15 examined the effects of multiple risk factors on atherosclerosis in 93 young persons between 2 and 39 years of age (average {approx}20 years). The severity of atherosclerosis increased as the number of risk factors increased, but the authors did not analyze the effects of nonlipid risk factors in the presence of a favorable lipoprotein profile.

Prevalence of Nonlipid Risk Factors
Table 1Up shows a high prevalence of nonlipid risk factors among these young people having a favorable lipoprotein profile. The high prevalence of smoking in PDAY cases (44%) is consistent with recent reports of prevalence of smoking among high school students16 and young adults,17 with the prevalence being highest (28.7%) among persons 18 to 24 years old. PDAY cases showed an even higher prevalence because we used an objective marker of smoking18 and because there is an association of smoking with high-risk behaviors that predispose those who smoke to traumatic death.19

The prevalence of hypertension among young white and black men and women observed in PDAY is consistent with prevalence of hypertension observed in a living population.20 Although only {approx}4% of PDAY cases had glycohemoglobin >=8%, indicating an average blood glucose >140 mg/dL during several weeks preceding death, this figure may underrepresent the true prevalence of insulin resistance and impaired glucose tolerance. Type II diabetes, elevated fasting glucose, and impaired glucose tolerance are increasing in prevalence,21 together with obesity, particularly in younger men and women.22

Implications for Prevention of CHD
The high prevalence of nonlipid risk factors indicates considerable potential to affect early atherosclerosis and subsequent CHD by modifying these risk factors even among those young people with a favorable lipoprotein profile. Changing the behavior of young people to reduce cardiovascular risk is a serious challenge and a difficult task. Efforts to modify diet in children by intervention in school lunch programs and by family counseling have achieved only limited success.23 24 The decline in adolescent and youth smoking since 1974 slowed after 1985 and now is reversed.25 Obesity is emerging as a major health problem.26

Despite the controversy over screening for blood cholesterol, diet modification, and drug treatment at early ages, there is little or no controversy over hygienic measures to control smoking, obesity, hypertension, and hyperglycemia in young persons. As demonstrated in the results presented here, these nonlipid risk factors substantially affect the extent and severity of coronary and aortic atherosclerosis even in individuals with a favorable lipoprotein profile. The earlier all the cardiovascular risk factors are controlled, as recommended by the AHA in 1992,27 the greater the potential for deferring the onset of CHD.


*    Acknowledgments
 
Institutions cooperating in the Pathobiological Determinants of Atherosclerosis in Youth study and supporting grants from the National Heart, Lung, and Blood Institute and other sources are as follows: University of Alabama, Birmingham, Ala, HL-33733, HL-33728; Albany Medical College, Albany, NY, HL-33765; Baylor College of Medicine, Houston, Tex, HL-33750; University of Chicago, Chicago, Ill, HL-33740, HL-45715; The University of Illinois, Chicago, Ill, HL-33758; Louisiana State University Medical Center, New Orleans, La, HL-33746, HL-45720; University of Maryland, Baltimore, Md, HL-33752, HL-45693; Medical College of Georgia, Augusta, Ga, HL-33772; University of Nebraska Medical Center, Omaha, Nebr, HL-33778; The Ohio State University, Columbus, Ohio, HL-33760, HL-45694; Southwest Foundation for Biomedical Research, San Antonio, Tex, HL-39913; gift of Peter and Beth Dahlberg; The University of Texas Health Science Center at San Antonio, San Antonio, Tex, HL-33749, HL-45719; Vanderbilt University, Nashville, Tenn, HL-33770, HL-45718; and West Virginia University Health Sciences Center, Morgantown, WV, HL-33748.


*    Footnotes
 
Reprint requests to Jack P. Strong, MD, Department of Pathology, Louisiana State University Medical Center, 1901 Perdido St, New Orleans, LA 70112-1393.

Received September 27, 2000; revision received November 21, 2000; accepted December 1, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Steinberg D, Gotto AM Jr. Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside. JAMA. 1999;282:2043–2050.[Abstract/Free Full Text]
  2. Sacks FM. Why cholesterol as a central theme in coronary artery disease? Am J Cardiol. 1998;82:14T–17T.[Medline] [Order article via Infotrieve]
  3. National Cholesterol Education Program [US]. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Bethesda, Md: National Heart, Lung, and Blood Institute, Health and Human Services Dept; 1993. NIH publication No. 93-3095.
  4. McGill HC Jr, McMahan CA, Malcom GT, et al. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol. 1997;17:95–106.[Abstract/Free Full Text]
  5. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–2478.[Abstract/Free Full Text]
  6. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995;15:1512–1531.[Abstract/Free Full Text]
  7. McGill HC Jr, McMahan CA, Zieske AW, et al. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation. 2000;102:374–379.[Abstract/Free Full Text]
  8. McGill HC Jr, McMahan CA, Malcom GT, et al. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 1995;15:431–440.[Abstract/Free Full Text]
  9. McGill HC Jr, McMahan CA, Tracy RE, et al. Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Arterioscler Thromb Vasc Biol. 1998;18:1108–1118.[Abstract/Free Full Text]
  10. Havel RJ, Rapaport E. Management of primary hyperlipidemia. N Engl J Med. 1995;332:1491–1498.[Free Full Text]
  11. McGill HC Jr, McMahan CA, Herderick EE, et al. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. Arterioscler Thromb Vasc Biol. 2000;20:836–845.[Abstract/Free Full Text]
  12. Auerbach O, Garfinkel L. Atherosclerosis and aneurysm of aorta in relation to smoking habits and age. Chest. 1980;78:805–809.[Abstract/Free Full Text]
  13. Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis. 1976;23:451–476.[Medline] [Order article via Infotrieve]
  14. Jee SH, Suh I, Kim IS, et al. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. JAMA. 1999;282:2149–2155.[Abstract/Free Full Text]
  15. Berenson GS, Srinivasan SR, Weihang B, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1998;338:1650–1656.[Abstract/Free Full Text]
  16. Centers for Disease Control. Cigarette smoking among high school students: 11 states, 1991–1997. JAMA. 1999;282:935–936.[Free Full Text]
  17. Centers for Disease Control. Cigarette smoking among adults: United States, 1997. JAMA. 1999;282:2115–2116.[Free Full Text]
  18. Kornitzer M, Vanhemeldonck A, Bourdoux P, et al. Belgian heart disease prevention project: comparison of self-reported smoking behaviour with serum thiocyanate concentrations. J Epidemiol Commun Health. 1983;37:132–136.[Abstract]
  19. Grout P, Cliff KS, Harman ML, et al. Cigarette smoking, road traffic accidents and seat belt usage. Public Health. 1983;97:95–101.[Medline] [Order article via Infotrieve]
  20. National Heart, Lung, and Blood Institute [US]. Hypertension prevalence and the status of awareness, treatment, and control in the United States: final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension. 1985;7:457–468.[Abstract/Free Full Text]
  21. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care. 1998;21:518–524.[Abstract]
  22. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529.[Abstract/Free Full Text]
  23. DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: the Dietary Intervention Study in Children (DISC). JAMA. 1995;273:1429–1435.[Abstract]
  24. Luepker RV, Perry CL, McKinlay SM, et al. Outcomes of a field trial to improve children’s dietary patterns and physical activity: the Child and Adolescent Trial for Cardiovascular Health (CATCH). JAMA. 1996;275:768–776.[Abstract]
  25. Wechsler H, Rigotti NA, Gledhill-Hoyt J, et al. Increased levels of cigarette use among college students: a cause for national concern. JAMA. 1998;280:1673–1678.[Abstract/Free Full Text]
  26. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522.[Abstract/Free Full Text]
  27. Strong WB, Deckelbaum RJ, Gidding SS, et al. Integrated cardiovascular health promotion in childhood: a statement for health professionals from the Subcommittee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1992;85:1638–1650.[Free Full Text]



This article has been cited by other articles:


Home page
PediatricsHome page
S. R. Daniels, F. R. Greer, and and the Committee on Nutrition
Lipid Screening and Cardiovascular Health in Childhood
Pediatrics, July 1, 2008; 122(1): 198 - 208.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. C. McGill Jr, C. A. McMahan, and S. S. Gidding
Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study
Circulation, March 4, 2008; 117(9): 1216 - 1227.
[Full Text] [PDF]


Home page
CirculationHome page
L. L. Hayman, J. C. Meininger, S. R. Daniels, B. W. McCrindle, L. Helden, J. Ross, B. A. Dennison, J. Steinberger, and C. L. Williams
Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth: A Scientific Statement From the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism
Circulation, July 17, 2007; 116(3): 344 - 357.
[Full Text] [PDF]


Home page
CirculationHome page
B. W. McCrindle, E. M. Urbina, B. A. Dennison, M. S. Jacobson, J. Steinberger, A. P. Rocchini, L. L. Hayman, and S. R. Daniels
Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing
Circulation, April 10, 2007; 115(14): 1948 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
X. SHEN and K. E. BORNFELDT
Mouse Models for Studies of Cardiovascular Complications of Type 1 Diabetes
Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 202 - 217.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt
Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?
Circ. Res., March 30, 2007; 100(6): 769 - 781.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Circulation, December 12, 2006; 114(24): 2710 - 2738.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. B. Lande, N. L. Carson, J. Roy, and C. C. Meagher
Effects of Childhood Primary Hypertension on Carotid Intima Media Thickness: A Matched Controlled Study
Hypertension, July 1, 2006; 48(1): 40 - 44.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
American Heart Association, S. S. Gidding, B. A. Dennison, L. L. Birch, S. R. Daniels, M. W. Gilman, A. H. Lichtenstein, K. T. Rattay, J. Steinberger, N. Stettler, et al.
Dietary Recommendations for Children and Adolescents: A Guide for Practitioners
Pediatrics, February 1, 2006; 117(2): 544 - 559.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al.
Managing Abnormal Blood Lipids: A Collaborative Approach
Circulation, November 15, 2005; 112(20): 3184 - 3209.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Endorsed by the American Academy of Pediatrics, S. S. Gidding, B. A. Dennison, L. L. Birch, S. R. Daniels, M. W. Gilman, A. H. Lichtenstein, K. T. Rattay, J. Steinberger, N. Stettler, et al.
Dietary Recommendations for Children and Adolescents: A Guide for Practitioners: Consensus Statement From the American Heart Association
Circulation, September 27, 2005; 112(13): 2061 - 2075.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. A. McMahan, S. S. Gidding, Z. A. Fayad, A. W. Zieske, G. T. Malcom, R. E. Tracy, J. P. Strong, H. C. McGill Jr, and for the Pathobiological Determinants of Atheroscle
Risk Scores Predict Atherosclerotic Lesions in Young People
Arch Intern Med, April 25, 2005; 165(8): 883 - 890.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. T. St. Jeor, L. L. Hayman, S. R. Daniels, M. W. Gillman, G. Howard, C. M. Law, C. E. Lewis, and E. Poehlman
Prevention Conference VII: Obesity, a Worldwide Epidemic Related to Heart Disease and Stroke: Group II: Age-Dependent Risk Factors for Obesity and Comorbidities
Circulation, November 2, 2004; 110(18): e471 - e475.
[Full Text] [PDF]


Home page
CirculationHome page
L. L. Hayman, C. L. Williams, S. R. Daniels, J. Steinberger, S. Paridon, B. A. Dennison, and B. W. McCrindle
Cardiovascular Health Promotion in the Schools: A Statement for Health and Education Professionals and Child Health Advocates From the Committee on Atherosclerosis, Hypertension, and Obesity in Youth (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association
Circulation, October 12, 2004; 110(15): 2266 - 2275.
[Full Text] [PDF]


Home page
PediatricsHome page
National High Blood Pressure Education Program Wor
The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents
Pediatrics, August 1, 2004; 114(2/S2): 555 - 576.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Oren, L. E. Vos, C. S. P. M. Uiterwaal, D. E. Grobbee, and M. L. Bots
Cardiovascular Risk Factors and Increased Carotid Intima-Media Thickness in Healthy Young Adults: The Atherosclerosis Risk in Young Adults (ARYA) Study
Arch Intern Med, August 11, 2003; 163(15): 1787 - 1792.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association
Management of Dyslipidemia in Children and Adolescents With Diabetes
Diabetes Care, July 1, 2003; 26(7): 2194 - 2197.
[Full Text] [PDF]


Home page
J Child NeurolHome page
J.-P. de Chadarevian, A. Legido, D. K. Miles, and C. D. Katsetos
Epilepsy, Atherosclerosis, Myocardial Infarction, and Carbamazepine
J Child Neurol, February 1, 2003; 18(2): 150 - 151.
[Abstract] [PDF]


Home page
CirculationHome page
T. O. Cheng
Prevention of Coronary Artery Disease Should Start in the Young
Circulation, November 13, 2001; 104 (20): e107 - e107.
[Full Text] [PDF]


Home page
CirculationHome page
R. M. Robertson
Women and Cardiovascular Disease : The Risks of Misperception and the Need for Action
Circulation, May 15, 2001; 103(19): 2318 - 2320.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGill, H. C.
Right arrow Articles by Strong, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGill, H. C., Jr
Right arrow Articles by Strong, J. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Diabetes Complications
*High Blood Pressure
*Nutrition
*Obesity
*Smoking
*Smoking and Youth
Related Collections